Member Info for Takayama

It’s meaningless generally. Sometimes MMs will post a tiny sell so the indicator can show that lower sale price. Some PIs may think the price is down and so sell. The generally illiquid nature these last few days /weeks means that MMs are in an easier position to pick up cheap stock. Could be to fill a large order.

Well, someone has got themselves a bargain! Bobber's got a point about newsflow in AIM. AIM is dominated by PIs who all behave a certain way, but again, I'm not bothered. Let them jump. It makes no material difference to the performance of the company. A 7am big news announcement will be met by a large MM imposed spike pre-opening. They won't be selling at the pre-RNS closing SP. They'll be selling at the expected close of that post-RNS day with some play for early buyers - those that got up early enough and beat the rush at 8am! GLA. Bargains to be had. This may become a proper value play as day traders move out.

I wouldn’t disagree with either point. On the point about bumps- all companies face them. The three wins I outlined below all have over 70% chance of ultimate success given stage of development and results so far. On news- my point is perhaps more about AIM CEOs feeding rises with news to feed sentiment and gossip-but that vapourises or leads to unfulfilled promises. None of that here-and that is good.

No worries at all guys. I'll point out that I'm not a ramper (nor a deramper) here. One thing I have learnt over the years is to bail when there isn't a plan! There definitely was a plan put into place when the SP crashed soon after floatation - and it's a good one. Top it all off with a leader in a new area of science, and all of a sudden you've got a player. So I get where Bobber is coming from, but I don't agree wiht where he has ended up. I was greedily eyeing up the hydrogen stocks in the last few weeks as an alternative area to shift funds too - and also in space (given the bubble that is just starting there with the impending Space X float), but have chosen to sit here instead, as at the moment, I feel we are overdue a spike. There are no practical reasons to sell. It won't be a straight road, but at the same time, we do have a road, whihc is more than a lot of AIM companies can say. GLA

I can see Bobber is not entirely understanding where the company is, and of course the change in pace of newsflow creates an atmosphere of change, which is naturally unsettling. I had a bit of spare time this lunchtime, so I'll just point out the following timelines and potential areas of impact:

(1) With Unilever: Late 2026-mid 2027 for a Unilever tie up, eventually bringing £1M to £5M yearly passive revenue.

(2) With AstraZeneca: There is a the liver fibrosis potential tie up, high chance of success, (Aptamer has built an Optimer delivery vehicle that specifically targets Hepatic Stellate Cells (HSCs)—the specific cells responsible for creating liver scar tissue. ) Late 2027 to early 2028 is the likely delivery timeline. The recent fundraising provided funds for in vivo to in vitro testing, shortening the timeline by around 12 months. The better balance sheet also derisked the company in the eyes of AstraZeneca, prompting them to fully resume collaborative work and contract progression without defensive operational delays. It's likely to bring a £5m payback, and subsequent payments beyond... .

Then there is the radiopharmaceutical work... .

The fundraising was directly tied to speeding up work, buying kit, so shortening the timeline to a self sustaining positive cashflow company. There are other things in the pipeline with comparatively (to the rest of the sector) higher chances of success – but admittedly late 2027 is when a lot of the work comes together to delivering licencing contracts, and we all know that we should bank to H1 2028. Two or three major licencing deals are likely to bring a stable re-rate of the share to multiples of where it is now as the company shifts from being seen as a one shot wonder micro-bio to one with a decent business model. The difficulty with selling now is that positive milestone news announcements are likely to cause spikes, that could be sustainable depending on sentiment. Daily Mail may just jump in again... . And then it could feel like it is too late to buy back in. Are there reasons to sell? If there is something with more certainty of a quicker rise elsewhere before the next bit of news here, perhaps. But that's a huge gamble given what is on the plate here I would say.

The fact that at this stage, a fund manager has bought in speaks volumes about the fund raise. Lack of news signals confidence in the product as far as AIM stocks are concerend. GLA.

Bubba, Astrazeneca and Unilever. Haven’t you research the company yet? LOL!

I wouldn’t worry about the lack of news too much either. If anything that signals slightly higher confidence in the company. No need to try and ramp with production of borderline ‘news’. There’re at least two significant royalty agreements in the pipeline which should signal a retaking. Both have a high chance of success given the advanced stage of testing.

It's like the sinking of the titanic here.

Bobber - the bulk of the money raised is for expansion. The minority is to derisk to cash positive. The retail trading that you refer to has little to do with the BOD etc. That’s how capitalism works. If you borrow to pour money down the sink, then of course the SP will fall. But that isn’t what’s happening here.

A bit difficult to find out exactly how many bottles of deodorant Unilever sells a year, but looking at the $6bn or so that Dove alone proved Unilever, assuming a third is deodorant, that’s around 600 million units of deodorant. Say Aptamer had around 1p of every unit, that’s still six million cash a year in just Dove deodorant. The business model speaks to this being eternal. A pretty good return for both Inilever and for Apta shareholders I would say. You can add Sure and Lynx to that too. Given we are expecting something by this time next year, I’d say this is a share price low entry point…

It’s just a case of positive news expected here. A positive news flow around a series of successes will help the dust to settle here and for this to revert to its upward trajectory

I see SpaceX has filed for a public listing today. That’s obviously going to set that whole sector off. Who was the sort of technology that I had hoped seed would be involved in. Given they aren’t, does anyone have any ideas? I’ve only seen Van. Eck’s Space fund….

Hey funny life. I was actually replying to Bobber who was saying that Nick Slater’s TP were going to sell . So if you go to the twin path website, you’ll see the list of their investments quite openly. Slater is here obviously on his own, for whatever reason TP decided not to invest in the first instance, it is a minor point. Don’t sweat it. And Slater would have to be a real loser to be posting on ADV FN.! LOL. Why on earth will be on a chat board, engaging with the likes of us small fry.?

Lol! Are you Gallery 30?!!!

Well, in terms of fundraising, this share is now pretty well de-risked. I was pleased that the bulk of the funds is intended to buy equipment designed to make the company 'bigger'. Anyone wanting to sell should have sold before the closure of the fund raise as they would have believed that the price would continue to fall. So buyers have been flushed out. I don't see any evidence that Nick Slater's TP is invested in APTA (doesn't appear on their website), nor that Nico on ADVFN is Nick Slater, nor that Nico is looking to sell their holdings (in fact their postings on ADVFN are pretty positiv.e). Looks to me like someone is trying to deramp! Lol! I genuinely can't see this going down at this point. Simply more upward movement. GLA

Some pretty chunky buys today. Anyone worrying would have sold into the expectation of poor sentiment, so I'd be surprised to see much more selling. The company fundamentals are pretty much the same as they were before the fundraising - and the fundraising was actually with institutions, which I find unusual for an AIM company! I guess once you knock off the Daily Mail effect (for it was their coverage that led to the meteoric rise), the valuation may be construed as fair for an institutional placing - rather than being the result of a mass sell off. But all bets are off now - any news on its way is going to push this upwards. I, for one, see this as an opportunity to buy. I can't see this lasting much longer... . Especially if there is a follow up Daily Mail article, because we know they are still looking at this.

Sentiment wasn’t hit in the end, and it looks like this indeed is the bottom and possibly the last chance to buy under 0.8. I can only see it going up from here. The big result will be Unilever and say we’ve got another 12 months to hear from that one which is plenty of time for this to ride the peaks of the rollercoaster. GLA.

I can't see the retail offer being successful. That's not going to bode well for sentiment and so the share price. Yoikes. A bit of an own goal that one. APTA - if you want me as an NED, I'd be happy to help.

Unfortunately if you have APTA in an ISA, which most of us do, you forfeit the warrants. Looks like this isn’t a good offer to the UK retail investor. Shame.

Ok, disappointing. It’s ok if this placing brings in double the return within a couple of years. Extending cash runway is poor reasoning. Who knows?